Physician profile
Mehulkumar Joshi
NPI 1124467709
$8,034.20
in general payments reported to CMS, 2019-2025
29 companies · $809 in 2025
The $809 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $431 · 2020: $1,216 · 2021: $1,179 · 2022: $692 · 2023: $1,226 · 2024: $2,481 · 2025: $809.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,958 · Consulting Fee: $1,885 · Travel and Lodging: $581 · Education: $91.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,958.30 |
| Consulting Fee | $1,884.93 |
| Travel and Lodging | $580.86 |
| Education | $91.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $2,680.92 | 2022-2024 | (6554) Peripheral Vascular Undivided |
| Medtronic Vascular, INC. | $1,408.81 | 2019-2020 | |
| Medtronic, INC. | $711.55 | 2021-2025 | Venaseal, Endurant Iis, Interstim |
| Endologix LLC | $690.70 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $535.13 | 2021-2024 | Xarelto |
| Boston Scientific Corporation | $501.84 | 2021-2025 | Varithena Administration Pack, Therasphere Y90 Glass Microspheres 10 Gbq, Enroute Transcarotid Stent |
| Shockwave Medical, INC | $217.06 | 2021-2025 | |
| Angiodynamics, INC. | $171.00 | 2020-2022 | |
| Reflow Medical INC | $158.49 | 2025 | |
| Bard Peripheral Vascular, INC. | $119.39 | 2020-2024 | Fluency Endovascular Stent Graft |
| Surmodics, INC. | $115.93 | 2024 | Pounce Thrombectomy |
| Veryan Medical Incorporated | $102.88 | 2021-2023 | Biomimics 3d Vascular Stent System |
| Imperative Care, INC | $85.27 | 2025 | Symphony Catheter |
| Cardiovascular Systems INC. | $57.04 | 2020-2023 | Diamondback Peripheral |
| Baxter Healthcare | $53.59 | 2024 | Renal - Chronic |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $53.40 | 2020-2022 | |
| Neuros Medical, INC. | $52.68 | 2025 | Altius |
| Bone Support INC. | $46.23 | 2025 | Ceramentbone Void Filler, Cerament G |
| Penumbra, INC. | $39.89 | 2023-2024 | Indigo System, Penumbra System |
| Organogenesis INC. | $38.20 | 2024 | |
| Cardiva Medical, INC. | $38.19 | 2023-2025 | Cardiva Vascade 5f Vcs, Cardiva Vascade 6/7f Vcs |
| Silk Road Medical, INC. | $33.32 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Lilly USA, LLC | $24.37 | 2025 | Zepbound |
| Mozarc Medical US LLC | $21.49 | 2024 | Permcath |
| Flowphysix INC | $16.25 | 2025 | Flowrunner |
| Argon Medical Devices, INC. | $15.98 | 2025 | Clot Management |
| Exact Sciences Corporation | $15.76 | 2025 | Cologuard Collection Kit |
| Terumo Medical Corporation | $14.73 | 2024 | Azur Cx Detachable, Glidewire |
| Acera Surgical, INC. | $14.11 | 2025 | Restrata Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mehulkumar Joshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.